2nd Quarter - Report
CONTINENTAL STRATEGY, LLC for IMMIX BIOPHARMA, INC.
Client
Income
$105,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
FDA approval standards
| Lobbyist | Covered position, as disclosed |
|---|---|
| LUKE NICKLESS | Senior Policy Advisor, Appropriations, House Committee on the Budget |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.